14:44:32 EDT Sat 22 Jun 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Treatment.com AI Inc
Symbol TRUE
Shares Issued 39,223,518
Close 2024-04-09 C$ 0.69
Market Cap C$ 27,064,227
Recent Sedar Documents

Treatment.com AI to work with aiXplain for GLM sales

2024-04-10 09:56 ET - News Release

Dr. Essam Hamza reports

TREATMENT.COM AI PARTNERS WITH AIXPLAIN INC. TO EXTEND ACCESS TO ITS GLOBAL LIBRARY OF MEDICINE (GLM)

Treatment.com AI Inc. has signed a collaborative agreement with aiXplain Inc. to enable greater access to Treatment's proprietary Global Library of Medicine (GLM) by contributing to aiXplain's ever-growing dynamic artificial intelligence (AI) marketplace.

Treatment has partnered with aiXplain, the industry's first no-code/low-code integrated AI development platform. Over the past seven years and in collaboration with hundreds of health care professionals globally, utilizing proprietary algorithms, Treatment has built the world's most intelligent, personalized health care AI engine, the Global Library of Medicine (GLM). aiXplain's marketplace makes it possible for health care organizations to access Treatment's AI engine through its development framework and enhance the quality of clinical diagnosis within their organizations across multiple platforms.

Treatment and aiXplain also intend to explore mutually beneficial international opportunities through the partnership. Both parties have a shared interest in the future to provide the GLM in multiple languages.

The collaboration also allows aiXplain and Treatment to work closely on testing and development of further new mutual joint commercial applications and/or solutions. The intent of this collaboration is to promote the development, installation, testing, validation and commercialization of one or more novel solutions that further the goals of both companies and proactively impact the health care market globally.

Dr. Essam Hamza, chief executive officer of Treatment.com AI, comments: "The opportunity to partner with aiXplain, an organization at the heart of the AI evolution, and to be part of their evolving marketplace is fantastic. It helps fulfill our shared philosophies in the democratization of AI. Our goal is to have Treatment's Global Library of Medicine (GLM) AI accessible to health care organizations and health care professionals alike, and aiXplain's marketplace creates new opportunities for all parties."

"Our partnership with Treatment represents another quality addition to our world-leading marketplace of AI models and assets," said Hassan Sawaf, chief executive officer and founder of aiXplain. "The news also marks a milestone for aiXplain. This is the first specialized AI model for the health care industry to join our marketplace, expanding the versatility of our AI platform across sectors."

About Treatment.com AI Inc.

Treatment.com AI is a company utilizing AI to positively disrupt the health care sector and impact current inefficiencies and challenges. Over the past seven plus years and with the input of hundreds of health care professionals globally, Treatment.com AI has built the world's most intelligent, personalized health care AI engine, the Global Library of Medicine (GLM). Providing the highest qualified clinical information and support to all health care professionals, the GLM delivers greater than 92 per cent plus accuracy on first diagnosis as well as providing recommended tests (physical and lab), X-rays and billing codes. The platform's quality and transparency are unrivalled, as the GLM provides an explanation of every step and likelihood associated with every symptom. Treatment.com AI also focuses on the next generation of health care professionals supporting medical and nursing schools, which utilize the GLM to help enhance the future clinical skills of their students. Treatment.com AI is focused on using AI for good and utilizing its GLM platform to bring the possibility of health equity and inclusion for disenfranchised communities.

About aiXplain Inc.

Founded in 2020, aiXplain has established itself as a pioneering force with the industry's premier no-code/low-code platform for AI development. Designed to democratize the creation and deployment of AI solutions, aiXplain's platform empowers users to effortlessly develop, manage, benchmark and deploy AI solutions. With access to an expansive marketplace featuring over 40,000 leading AI models and assets, aiXplain's customers are equipped to tailor advanced solutions to their specific needs, streamlining the path from concept to deployment.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.